GGrantIndex
← Leaderboards

Health Decisions, Inc.

Durham, NC

Compare ↔
$72,510,785
Total funding
12
Grants

Funding over time

peak $8.7M · FY200825
$10M$7.5M$5M$2.5M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$72,510,785 · 12

By mechanism

N01$72,510,785 · 12

Investigators at Health Decisions, Inc.

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

Not enough data

Emerging Leaders

6–10 yrs in

Not enough data

All-Time

Most funded here, all years

Not enough data

Largest grants

CONTRACEPTIVE CLINICAL TRIALS NETWORK, CLINICAL EVALUATION OF LARC METHODS TO DETERMINE COMPARATIVE EFFECTIVENESS, ACCEPTABILITY, AND SAFETY.$5,092,228
N01 · FY2018 · HD
CCTN - COORDINATION OF CLINICAL TRIALS OF NOVEL PRODUCTS FOR FEMALE CONTRACEPTION$4,499,792
N01 · FY2016 · HD
STATISTICAL AND CLINICAL COORDINATING CENTER FOR CCTN (SCCC)$3,774,093
N01 · FY2012 · HD
CONTRACEPTIVE CLINICAL TRIAL NETWORK (FEMALE)$3,452,203
N01 · FY2010 · HD
CCTN - COORDINATION OF CLINICAL TRIALS OF NESTORONE TESTOSTERONE GEL FOR MALE CONTRACEPTION$3,262,997
N01 · FY2022 · HD
COORDINATION OF CLINICAL TRIALS OF NESTORONE TESTOSTERONE GEL FOR MALE CONTRACEPTION$3,186,959
N01 · FY2021 · HD
STATISTICAL AND CLINICAL COORDINATING CENTER FOR CCTN (SCCC)$3,128,002
N01 · FY2012 · HD
COORDINATION, MONITORING, FOLLOW-UP, AND EVALUATION OF A CLINICAL TRIAL OF NESTORONE TESTOSTERONE GEL FOR MALE CONTRACEPTION$2,968,765
N01 · FY2023 · HD
STATISTICAL AND CLINICAL COORDINATING CENTER FOR CCTN$2,849,760
N01 · FY2017 · HD
COORDINATION, MONITORING, FOLLOW-UP, AND EVALUATION OF A CLINICAL TRIAL OF NESTORONE TESTOSTERONE GEL FOR MALE CONTRACEPTION$2,779,148
N01 · FY2024 · HD
COORDINATION OF CLINICAL TRIALS OF NESTORONE TESTOSTERONE GEL FOR MALE CONTRACEPTION$2,360,737
N01 · FY2017 · HD
CONTRACEPTIVE CLINICAL TRIALS NETWORK, CLINICAL EVALUATION OF LARC METHODS TO DETERMINE COMPARATIVE EFFECTIVENESS, ACCEPTABILITY, AND SAFETY.$2,353,361
N01 · FY2021 · HD
CONTRACEPTIVE CLINICAL TRIALS NETWORK, CLINICAL EVALUATION OF LARC METHODS TO DETERMINE COMPARATIVE EFFECTIVENESS, ACCEPTABILITY, AND SAFETY.$1,708,787
N01 · FY2022 · HD
CORE SUPPORT FOR NICHD CCTN$1,702,875
N01 · FY2009 · HD
STATISTICAL AND CLINICAL COORDINATING CENTER FOR CCTN (SCCC)$1,499,988
N01 · FY2016 · HD
STATISTICAL AND CLINICAL COORDINATING CENTER FOR CCTN (SCCC)$1,498,148
N01 · FY2012 · HD
CONTRACEPTIVE CLINICAL TRIALS NETWORK$1,425,854
N01 · FY2008 · HD
CCTN - COORDINATION OF CLINICAL TRIALS OF NOVEL PRODUCTS FOR FEMALE CONTRACEPTION$1,403,060
N01 · FY2019 · HD
CONTRACEPTIVE CLINICAL TRIALS NETWORK$1,306,204
N01 · FY2009 · HD
STATUS DETERMINATION AND PRIORITIZATION OF PIPELINE PRODUCTS UNDERGOING CLINICAL TRIALS FOR MALE AND FEMALE CONTRACEPTION$1,295,609
N01 · FY2019 · HD